Ceftrica S 1000 mg/500 mg Injection
By Ceftrica S
Rx
2ml Injection in a Vial

Composition
Ceftriaxone(1000mg) + Sulbactam(500mg)

Manufacturer - Molekule India Pvt Ltd
CRIMPAGE CORPORATION, 3RD FLOOR, PLOT NO. 57, STREET NO. 17, MIDC, MAROL, ANDHERI (EAST), MUMBAI MH 400093 IN , - , .

Expires on or after
October, 2025

liver
When using Ceftrica S 1000 mg/500 mg Injection, it is important to be cautious if you have severe liver disease. In such cases, a dose adjustment may be necessary, and it is advisable to consult your doctor. However, for individuals with mild to moderate liver disease, dose adjustment of Ceftrica S 1000 mg/500 mg Injection is generally not recommended. It's crucial to consider your liver health when using this medication to ensure its safety and effectiveness.

kidney
Limited information exists on using Ceftrica S 1000 mg/500 mg Injection in patients with kidney disease. Kindly seek advice from your doctor for guidance.

alcohol
It is safe to consume alcohol with Ceftrica S 1000 mg/500 mg Injection with no harmful side effects.

driving
Ceftrica S 1000 mg/500 mg Injection can reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these side effects.

pregnancy
Ceftrica S 1000 mg/500 mg Injection is generally considered safe to use during pregnancy based on animal studies showing low risk to the developing baby. Limited human studies are available.

breastfeeding
Ceftrica S 1000 mg/500 mg Injection needs caution while breastfeeding. It's advisable to pause breastfeeding until the mother's treatment is done and the drug is cleared from her system.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹125
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024